期刊文献+

如何正确理解抗真菌药物体外敏感试验结果对临床用药的指导价值 被引量:20

How to interpret the guidance value of in vitro susceptibility test of anti-fungal drugs on dinical practice
原文传递
导出
摘要 随着临床侵袭性真菌感染患者的增加,真菌疾病的诊断和治疗倍受关注,临床亟须实验室在真菌鉴定和药敏方面提供帮助。本文将围绕临床和实验室共同关心的几个问题展开阐述,包括抗真菌药物体外药敏的发展历史和方法学进展,酵母菌和丝状真菌体外药敏的判读,折点解释以及对于临床的指导意义。本文同时紧密结合临床常用的几种抗真菌药物,以期从操作层面帮助实验室提高真菌药敏的工作水平,帮助临床更好地理解各种抗真菌药物的体外药敏结果。 The diagnosis and treatment of invasive fungal infections has been attracting more and more attention along with the increase incidence in the current clinical practice. We hereby work out this paper to elaborate some key issues, covering the history and methodology of anti-fungal susceptibility testing, the MIC recognition of yeast fungus and mycelial fungus, breakpoint interpretation, and finally the guidance for clinical practice. To better understand susceptibility test results and improve the guality of susceptibility tests in this review,we chosed several most-often used anti-fungal drugs and explained their effect activity.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2008年第2期128-132,共5页 Chinese Journal of Laboratory Medicine
关键词 真菌病 抗真菌病 微生物敏感性试验 Mycoses Antifungal agents Microbial sensitivity tests
  • 相关文献

参考文献13

  • 1M27-A2 Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2nd ed. 2002.22(15):1-30.
  • 2M38-A, Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, Approved Standard. 2002.22(16):1-30.
  • 3Lass-florl C, Kofler G, Kropshofer G, et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicro Chemoth, 1998,42:497-502.
  • 4王澎,陈翠珠,徐英春,谢秀丽,王瑶,王辉,陈民钧.4种抗真菌药对82株丝状真菌体外抗菌活性的临床研究[J].中国实用内科杂志,2006,26(4):547-549. 被引量:5
  • 5Pfaller MA, Boyken L, Hollis RJ,et al. In vitro susceptibilities of clinical isolates of Candida species, cryptococcus neoformans, and Aspergillus species to itraconazole:global survey of 9359 isolates tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods. J Clin Microb ,2005,43:3807-3810.
  • 6Willems L, van der C, eest R, de Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Phar Ther, 2001,26:159-169.
  • 7Fothergill AW, Rinaldi MG,Sutton DA. Antifungal susceptibility testing. Infect Dis Clin North Am,2006,20:699-700.
  • 8Pfaller MA, Diekema D J, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint of the future for antifungal susceptibility testing. Clin Microbiol Rev,2006,19:435-447.
  • 9Rex JH,Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis,2002,35:982-989.
  • 10刘伟,李若瑜.抗真菌药物敏感性试验在真菌感染防治中的作用[J].中华检验医学杂志,2005,28(4):349-351. 被引量:30

二级参考文献7

共引文献33

同被引文献151

引证文献20

二级引证文献196

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部